Colonial Trust CO / Sc Harvard Bioscience Inc Transaction History
Colonial Trust CO / Sc
- $529 Million
- Q1 2024
A detailed history of Colonial Trust CO / Sc transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Colonial Trust CO / Sc holds 954 shares of HBIO stock, worth $3,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
954
Previous 954
-0.0%
Holding current value
$3,148
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HBIO
# of Institutions
96Shares Held
33MCall Options Held
4KPut Options Held
2.2K-
B. Riley Asset Management, LLC Dallas, TX2.83MShares$9.36 Million5.14% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$9.35 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$9.15 Million0.71% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$8.44 Million1.17% of portfolio
-
Amh Equity LTD2.32MShares$7.67 Million10.16% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $137M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...